Go to the list of all blogs
Allana's Avatar
published in Blogs
Aug 05, 2026
Why Is Criteo S.A. (CRTO) Stock Down -24.24% Today?

Why Is Criteo S.A. (CRTO) Stock Down -24.24% Today?

Key Takeaways

  • Criteo S.A. (CRTO) shares plunged approximately 24.24% on Wednesday, falling from a prior close of $22.40 to around $16.97, following the release of second-quarter 2026 earnings.
  • Despite beating consensus estimates on both adjusted EPS ($0.80 vs. $0.70) and revenue ($428M vs. $263.51M), investors fixated on sharply reduced full-year guidance.
  • The company now expects fiscal 2026 Contribution ex-TAC to decline 10% to 12% at constant currency, citing reduced spending from several large enterprise clients in Performance Media.
  • Revenue fell 11% year-over-year, net income dropped 49% to $12 million, and free cash flow turned negative at -$38 million for the quarter.
  • The sell-off reflects broader fears that enterprise ad spending softness may persist through the remainder of 2026, overshadowing the company's AI-driven strategic initiatives.
  • Traders are now watching whether the newly announced CFO transition and OpenAI partnership can restore confidence in the coming quarters.

Opening Summary

CRTO, the global commerce intelligence platform formerly known primarily as a retargeting specialist, saw its shares crater on Wednesday after the company delivered a stark second-quarter 2026 earnings report that exposed a widening gap between ambitious long-term AI ambitions and deteriorating near-term fundamentals. The stock fell roughly 24.24% to approximately $16.97 from Tuesday's close of $22.40, wiping out months of gains and pushing the market capitalization well below the $1 billion mark. While the headline numbers beat Wall Street estimates, the market's verdict was swift and unforgiving: Criteo's guidance cut signals deeper trouble in enterprise advertising spending that management does not expect to reverse this year.

Q2 Earnings: A Beat That Didn't Matter

On the surface, Criteo's second-quarter results appeared respectable. The company posted adjusted diluted earnings of $0.80 per share, handily exceeding the $0.70 consensus estimate. Revenue of $428 million also came in well above the $263.51 million analysts had forecast. Media spend — a key indicator of client engagement — rose 9% year-over-year at constant currency to $1.1 billion, and adjusted EBITDA of $73 million topped the company's own guidance range.

But those headline beats masked serious deterioration underneath. GAAP revenue declined 11% from the prior-year quarter's $483 million. Gross profit fell 14% to $222 million, and net income nearly halved to $12 million from $23 million a year earlier. Diluted GAAP EPS was just $0.22, down 44% from $0.39 in Q2 2025. Contribution ex-TAC, the company's preferred profitability metric, dropped 12% at constant currency to $255 million — and that figure itself fell below the midpoint of management's prior guidance.

Guidance Slashed: The Real Catalyst for the Sell-Off

If the Q2 numbers raised alarms, the updated outlook confirmed investors' worst fears. Criteo now expects full-year 2026 Contribution ex-TAC to decline 10% to 12% at constant currency, a dramatic downgrade from previous expectations. For the third quarter, the company guided Contribution ex-TAC to a range of $237 million to $241 million, implying a year-over-year decline of 14% to 15%.

CEO Michael Komasinski did not mince words on the earnings call: "The second quarter was a challenging one for Criteo. We did not meet the expectations we set for ourselves." He attributed the shortfall to "pronounced client-specific Performance Media dynamics," pointing to reduced budgets from a handful of large enterprise customers whose spending cuts accelerated during the quarter. Among the causes cited were travel-sector disruptions tied to Middle East conflict, tariff and de minimis import-rule changes, and clients shifting marketing investment toward other parts of the funnel.

The revised outlook assumes no recovery in spending from those large enterprise clients for the remainder of 2026, a sobering admission that rattled investors who had hoped for a second-half rebound.

Retail Media and AI Partnerships: Bright Spots Overshadowed

Not all of Criteo's news was negative. The company's Retail Media segment showed underlying momentum, with same-retailer Contribution ex-TAC retention reaching 113% when excluding the impact of the largest retailer relationship changes. Excluding a previously disclosed $21 million headwind from scope changes with two specific Retail Media clients, underlying Retail Media Contribution ex-TAC grew 20% year-over-year.

Criteo also highlighted its position as OpenAI's first advertising technology partner, with over 2,000 brands now advertising on ChatGPT across seven countries. Sponsored products launched into AI-powered conversational search with Albertsons, and the Retail Media footprint expanded with new partnerships including Loblaw Advance in Canada and Olive Young in APAC. However, management acknowledged that these next-generation AI initiatives will not meaningfully contribute to 2026 financial results, leaving investors to wait until 2027 for any tangible payoff.

Leadership Transition Adds Uncertainty

Adding to the day's turbulence, Criteo announced that CFO Sarah Glickman, who served in the role for six years, will be succeeded by Connor McGogney effective August 10, 2026. While framed as a planned transition with Glickman staying on as an advisor through September, CFO changes during periods of financial headwinds often amplify investor unease. The company also disclosed it repurchased $30 million in shares during Q2 and completed its redomiciliation from France to Luxembourg, with plans to transfer domicile to the United States by January 2027.

Market Context and Trading Activity

The magnitude of CRTO's decline far outpaced broader market movements and sector peers. The stock gapped down at the open to approximately $16.46 before trading near $16.97, placing it just above its 52-week low of $15.58 and dramatically below its 52-week high of $25.29. Trading volume surged well above average as institutional investors recalibrated positions. The stock sliced through both its 50-day moving average of approximately $19.73 and its 200-day moving average near $18.80, breaching key technical support levels and triggering additional momentum-driven selling.

The advertising technology sector has faced persistent pressure from macroeconomic uncertainty and shifting enterprise spending patterns, but Criteo's single-day wipeout stood out as particularly severe — reflecting the concentrated nature of its client exposure and the market's disappointment that strategic AI investments have yet to translate into revenue growth.

What Comes Next for CRTO

The road ahead for CRTO hinges on whether management can stabilize Performance Media spending trends and demonstrate that Retail Media's underlying growth trajectory can eventually offset the drag from large-client scope reductions. The OpenAI partnership and broader agentic AI initiatives represent a potentially transformative pivot, but with no material revenue contribution expected until 2027, patience will be required.

Key risks include the possibility that additional large clients reduce spending, further macroeconomic deterioration that pressures advertising budgets, and execution risk surrounding the CFO transition and U.S. redomiciliation. On the flip side, the company's strong balance sheet — with $767 million in total financial liquidity and no long-term debt — provides a cushion for continued investment and share repurchases. With the stock trading near multi-year lows and analysts maintaining a consensus "Moderate Buy" rating, contrarian investors may begin evaluating whether the sell-off represents an overreaction or a rational repricing of diminished growth prospects.

Trending AI Robots

For traders seeking to navigate volatile market environments like the one impacting CRTO, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Tickeron provides hundreds of automated trading bots covering thousands of tickers across diverse strategies, timeframes, and performance profiles, but only the strongest performers under current market dynamics are featured in this rotating selection. Each bot is evaluated on real-time performance metrics, giving traders a data-driven lens into which strategies are thriving. Explore the Trending AI Robots to discover AI-driven trading solutions aligned with today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CRTO

CRTO in -2.60% downward trend, declining for three consecutive days on August 03, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where CRTO declined for three days, in of 307 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for CRTO moved out of overbought territory on July 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for CRTO turned negative on July 21, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for CRTO entered a downward trend on July 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where CRTO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 04, 2026. You may want to consider a long position or call options on CRTO as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CRTO moved above its 50-day moving average on June 29, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CRTO crossed bullishly above the 50-day moving average on July 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The 50-day moving average for CRTO moved above the 200-day moving average on July 30, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CRTO advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

CRTO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CRTO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.994) is normal, around the industry mean (49.094). P/E Ratio (10.516) is within average values for comparable stocks, (46.164). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.574). CRTO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.045). P/S Ratio (0.622) is also within normal values, averaging (28.994).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRTO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

Notable companies

The most notable companies in this group are Trade Desk (The) (NASDAQ:TTD).

Industry description

Making a brand known to people, garnering more clients/consumers for its product and solidifying the brand’s position in an industry – all of these are essential to a company’s growth, and that’s where marketing/advertising come in as one of the key catalysts. Advertising industry is a global multibillion-dollar business of public relations and marketing companies, media services and advertising agencies – entities that help to connect manufacturers/producers with customers. Digital media has played a big role in the growth of global advertising, and agencies invest substantially to integrate advanced technologies into their business operations. According to some estimates, the U.S. advertising industry is expected to generate revenue of $52.6 billion by 2023, up from almost $40 billion in 2015 . Omnicom Group Inc., Trade Desk, Inc. and Interpublic Group of Companies, Inc. are some of the major U.S. companies in the industry.

Market Cap

The average market capitalization across the Advertising/Marketing Services Industry is 4.99B. The market cap for tickers in the group ranges from 10.35K to 140.99B. APP holds the highest valuation in this group at 140.99B. The lowest valued company is MMND at 10.35K.

High and low price notable news

The average weekly price growth across all stocks in the Advertising/Marketing Services Industry was 2%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 8%. MF experienced the highest price growth at 43%, while BAOS experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Advertising/Marketing Services Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was 4% and the average quarterly volume growth was -27%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 67
Price Growth Rating: 58
SMR Rating: 88
Profit Risk Rating: 96
Seasonality Score: -14 (-100 ... +100)
View a ticker or compare two or three
CRTO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a global technology company

Industry AdvertisingMarketingServices

Profile
Details
Industry
Internet Software Or Services
Address
32 Rue Blanche
Phone
+33 175850939
Employees
3649
Web
https://www.criteo.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.